Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The conclusion is that a brown halo around hair follicles, seen in rapid hair loss, might be linked to inflammation or chemical exposure.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Inflammation affects hair loss; anti-inflammatory treatments may help.

Genetic testing can help diagnose skin conditions but needs more research for full effectiveness.

Both mouse and rat models are effective for testing alopecia areata treatments.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.